Core Insights - SI-BONE, Inc. will participate in the Canaccord Genuity 45th Annual Growth Conference in Boston, MA, on August 12, 2025 [1] - The company has pioneered minimally invasive SI joint surgery since 2009 and has supported over 4,600 physicians in performing over 125,000 procedures [3] Company Overview - SI-BONE is a global leader in developing technologies for surgical treatment of sacropelvic disorders [3] - The company has a strong clinical foundation with over 175 peer-reviewed publications, including four randomized controlled trials [3] - SI-BONE has expanded its offerings to adjacent markets, including adult deformity, spinopelvic and sacropelvic fixation, and pelvic trauma [3] Conference Participation - Management will host a fireside chat at the conference on August 12, 2025, at 12:00 p.m. Pacific Time [1] - Investors can register for the conference call and access the live audio webcast through the company's website [2]